×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALXO – alx oncology holdings inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALXO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
09:00 am
alxo
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
Low
Report
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
3/10
08:03 am
alxo
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
3/8
06:42 am
alxo
ALX Oncology initiated with a Buy at UBS [Yahoo! Finance]
Low
Report
ALX Oncology initiated with a Buy at UBS [Yahoo! Finance]
3/6
10:58 am
alxo
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
3/3
11:42 pm
alxo
ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]
Medium
Report
ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]
3/1
09:26 am
alxo
ALX Oncology: Evorpacept For ASPEN-09 Presses On With 2 Key Milestones [Seeking Alpha]
Medium
Report
ALX Oncology: Evorpacept For ASPEN-09 Presses On With 2 Key Milestones [Seeking Alpha]
2/28
09:03 am
alxo
ALX Oncology Holdings Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
ALX Oncology Holdings Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
06:12 pm
alxo
ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing [Seeking Alpha]
Low
Report
ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
2/27/2026
08:00 am
alxo
alx oncology holdings inc.
MISS
Report
-13.5%
alx oncology holdings inc.
11/7/2025
08:15 am
alxo
alx oncology holdings inc.
MISS
Report
15.0%
alx oncology holdings inc.
8/12/2025
04:05 pm
alxo
alx oncology holdings inc.
MISS
Report
8.7%
alx oncology holdings inc.
5/8/2025
08:30 am
alxo
alx oncology holdings inc.
MISS
Report
-2.1%
alx oncology holdings inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/9
04:04 pm
alxo
Form 10-K ALX ONCOLOGY HOLDINGS For: Dec 31
Medium
Report
Form 10-K ALX ONCOLOGY HOLDINGS For: Dec 31
3/5
04:05 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Mar 03 Filed by: Klencke Barbara
Medium
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Mar 03 Filed by: Klencke Barbara
3/5
04:01 pm
alxo
Form 3 ALX ONCOLOGY HOLDINGS For: Feb 25 Filed by: Klencke Barbara
Medium
Report
Form 3 ALX ONCOLOGY HOLDINGS For: Feb 25 Filed by: Klencke Barbara
2/27
08:05 am
alxo
Form 8-K ALX ONCOLOGY HOLDINGS For: Feb 27
High
Report
Form 8-K ALX ONCOLOGY HOLDINGS For: Feb 27
2/20
04:01 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Feb 18 Filed by: Pinto Shelly
Low
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Feb 18 Filed by: Pinto Shelly
2/19
09:02 pm
alxo
Form 4 ALX ONCOLOGY HOLDINGS For: Feb 17 Filed by: Lettmann Jason
Medium
Report
Form 4 ALX ONCOLOGY HOLDINGS For: Feb 17 Filed by: Lettmann Jason
2/9
05:02 pm
alxo
Form SCHEDULE 13G ALX ONCOLOGY HOLDINGS Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13G ALX ONCOLOGY HOLDINGS Filed by: RA CAPITAL MANAGEMENT, L.P.
2/6
04:43 pm
alxo
Form SCHEDULE 13G ALX ONCOLOGY HOLDINGS Filed by: TCG Crossover GP II, LLC
High
Report
Form SCHEDULE 13G ALX ONCOLOGY HOLDINGS Filed by: TCG Crossover GP II, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: